If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password
If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password
Peripheral vertigo, toxic/metabolic changes, seizure, migraine and functional disorders are the most common stroke mimics.
•
One out of four mimics is thrombolyzed with a very good outcome.
•
Patient evaluation by should be carried by physicians experienced in the diagnosis of both ischemic stroke stroke and mimics.
Abstract
Background
Ischemic stroke is the leading cause of disability and one of the leading causes of death. Ischemic stroke mimics (SMs) can account for a noteble number of diagnosed acute strokes and even can be thrombolyzed.
Methods
The aim of our comprehensive review was to summarize the findings of different studies focusing on the prevalence, type, risk factors, presenting symptoms, and outcome of SMs in stroke/thrombolysis situations.
Results
Overall, 61 studies were selected with 62.664 participants. Ischemic stroke mimic rate was 24.8% (15044/60703). Most common types included peripheral vestibular dysfunction in 23.2%, toxic/metabolic in 13.2%, seizure in 13%, functional disorder in 9.7% and migraine in 7.76%. Ischemic stroke mimic have less vascular risk factors, younger age, female predominance, lower (nearly normal) blood pressure, no or less severe symptoms compared to ischemic stroke patients (p < 0.05 in all cases). 61.7% of ischemic stroke patients were thrombolysed vs. 26.3% among SMs (p < 0.001). (p < 0.001). Overall intracranial hemorrhage was reported in 9.4% of stroke vs. 0.7% in SM patients (p < 0.001). Death occurred in 11.3% of stroke vs 1.9% of SM patients (p < 0.001). Excellent outcome was (mRS 0–1) was reported in 41.8% ischemic stroke patients vs. 68.9% SMs (p < 0.001). Apart from HINTS manouvre or Hoover sign there is no specific method in the identification of mimics. MRI DWI or perfusion imaging have a role in the setup of differential diagnosis, but merit further investigation.
Conclusion
Our article is among the first complex reviews focusing on ischemic stroke mimics. Although it underscores the safety of thrombolysis in this situation, but also draws attention to the need of patient evaluation by physicians experienced in the diagnosis of both ischemic stroke and SMs, especially in vertigo, headache, seizure and conversional disorders.
Ischemic stroke is the leading cause of disability and one of the leading causes of death. Enourmous efforts have been recently made to improve the clinical outcome of stroke patients including testing up comprehensive stroke units and the introducting endovascular procedures [
]. The benefit of revascularisation procedures (both intravenous thrombolysis and endovascular procedures) is time-dependent, therefore shortening door-to-needle time is crucial in the emergency department [
]. Ischemic stroke is usually an exclusionary clinical diagnosis in the emergency room, usually supported by noncontrast computed tomography (NCCT), which is the first step in the evaluation of ischemic stroke patients due to its widespread availability and relatively short imaging time [
2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2018;49:e46–e99.
However, the increased availability of systemic thrombolysis and shortened door-to-needle time have lead to inappropiate inclusion and treatment of so-called ischemic stroke mimics (ie. non-stroke patients) [
]. Ischemic stroke mimics can account for approximately one in five clinically diagnosed acute ischemic strokes and the rate of thrombolyzed mimics can be as high as 17% [
Misra S, Montaner J, Ramiro L, Arora R, Talwar P, Nath M, Kumar A, Kumar P, Pandit AK, Mohania D, Prasad K, Vibha D. Blood biomarkers for the diagnosis and differentiation of stroke: A systematic review and meta-analysis. Int J Stroke. 2020:1747493020946157.
Multimodal patient imaging (both CT and MR perfusion techniques) is an important part of acute ischemic stroke imaging to delineate the infarct from ischemic penumbra in specific situations such as stroke of unknown time of onset (SUTO) or in endovascular intervention with extended time window [
Despite of increasing number of publications in the last three decades, no comprehensive review has summarized the complex etiology, potential maltreatment and outcome of ischemic stroke mimics, especially in emergency situations.
The aim of our review article was to summarize the findings of different studies focusing on the prevalence, type, risk factors, presenting symptoms, and outcome of mimics in ischemic stroke/thrombolysis situations.
2. Methods
We searched PubMed, MEDLINE, and the Cochrane Library restricted to English language publications to January 2020. We used these search items in the following combinations: stroke, ischemic stroke, mimic, thrombolysis, rt-PA, alteplase, imaging, outcome, and mortality. After reviewing the abstracts, we obtained and reviewed the full text and reference lists of relevant articles.
3. Statistical analysis
Participants of the relevant studies were divided into two groups: (1) ischemic stroke patients, and (2) ischemic stroke mimics. Ischemic stroke mimic types, clinical findings, risk factors, thrombolysis rates and outcomes were compared between the two groups. Data were evaluated as means ± SD (standard deviation) by Student’s t-test or chi square test to detect significant differences among the examined parameters. Data analysis was performed using SPSS (version 22.0, IBM, New York, NY, USA).
4. Results
Overall, 61 studies were selected with 62,664 participants [
Pearson C, Przyklenk K, Mika VH, Ayaz SI, Ellis M, Varade P, Tolomello R, Welch RD. Utility of point of care assessment of platelet reactivity (using the PFA-100®) to aid in diagnosis of stroke. Am J Emerg Med. 2017;35(5):802.e1‐802.e5.
Systolic blood pressure as a predictor of transient ischemic attack/minor stroke in emergency department patients under age 80: a prospective cohort study.
Baseline characteristics of the 1149 patients recruited into the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2) randomized controlled trial.
BE FAST Study Group. Diagnostic accuracy of plasma glial fibrillary acidic protein for differentiating intracerebral hemorrhage and cerebral ischemia in patients with symptoms of acute stroke.
]. There were five prospective multicenter, one observational prospective, 17 prospective single center, 9 retrospective multicenter and 30 retrospective single center study (Supplementary Table 1).
Stroke mimic rate was 24.9% overall (15595/62664). Stroke mimic rate based on study type can be seen in Supplementary Table 1.
4.1 Mimic types
Ischemic stroke mimic types were the following: peripheral vestibular dysfunction in 23.2% (1109/4769 based on 15 studies /11, 16, 22, 26, 30, 32, 44, 46, 51, 61,65, 66, 69, 70, 71/), toxic/metabolic in 13.2% (1053/7985, based on 15 studies /11, 16, 22, 26, 30, 32, 44, 46, 51, 61, 65, 66, 69, 70, 71/), seizure in 13% (1257/9629, based on 11 studies /11, 25, 26, 28, 32, 33, 36, 53, 64, 68, 71/), functional disorder in 9.7% (373/3822 based on 12 studies /11, 14, 16, 17, 22, 41, 51, 59, 61, 69, 70, 71/) and migraine in 7.76% (697/8983, based on 36 studies /11, 14, 16, 17, 18, 20, 22–25, 27, 28, 30, 32, 33–47, 71/). Other etiologies were collapse/presyncope in 5.95% (464/7858 /11, 16, 18, 20, 22, 25–27, 30, 32, 35, 37, 38, 43, 44, 46, 47, 51, 53, 54, 59, 61, 62, 66, 69, 70/), sepsis in 5.3% (265/4823 /11, 16, 17, 23–25, 32, 33, 37, 38, 42, 43, 54, 60, 61, 69, 70,71/), mononeuropathy in 5% (including those with Bell's palsy, radial nerve palsy, oculomotor or abducens nerve palsies, but proper data are lacking) (162/3213 /11, 14, 16, 41, 61, 66, 70/), space-occupying lesion in 4.3% (299/6897 /11,16–18, 24, 26–28, 30, 34, 37, 38, 43, 46–48, 51, 54, 61, 64–66, 69, 70/), acute confusion in 1.9% (84/4344 /11, 14, 16, 34, 38, 44, 59, 70/). dementia in 1.2% (54/4577 /11, 16, 23, 33, 34, 38, 43, 46, 51, 54, 55, 61, 69, 70/) and spinal lesion in 0.7% (22/2939 /11, 16, 20, 25, 43, 61/) (Fig. 2). 9.69 % had non defined etiology which was not entirely clarified including Susac syndrome, obstructive hydrocephalus, transient global amnesia etc. (Fig. 1).
SM patients had significantly lower NIHSS (4.99 ± 5.65 vs. 8.06 ± 6.37, p < 0.001 /11, 14, 15, 19, 20–22, 24, 26, 28, 30, 34, 37, 41, 42, 45, 47, 49, 52, 53, 55, 58, 59, 61, 63–67, 69, 70/)), they were younger (60.9 ± 10.4 vs. 68.4 ± 9.7 years, p < 0.001 /11, 14, 15, 18–31, 33–50, 52, 53, 55–59, 61–71/) with female predominance (68 vs 56 %, p < 0.001 /11, 14, 15, 17–30, 32–53, 5–57, 59, 61–71/). The median time to onset from presentation was not significant between SM and ischemic stroke patients (116.75 ± 53.03 vs. 134.45 ± 58.27 min, p = 0.5 /11, 22, 26, 30, 31, 41, 42, 55, 56, 65, 70/).
Average blood pressure was 153.75/86.45 Hgmm in ischemic stroke and 140.25/83.1 Hgmm in SM patients (p < 0.001) [
Pearson C, Przyklenk K, Mika VH, Ayaz SI, Ellis M, Varade P, Tolomello R, Welch RD. Utility of point of care assessment of platelet reactivity (using the PFA-100®) to aid in diagnosis of stroke. Am J Emerg Med. 2017;35(5):802.e1‐802.e5.
Baseline characteristics of the 1149 patients recruited into the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2) randomized controlled trial.
Woke up symptoms were presented in 27.9% (211/757) in SM vs. 24.6% (278/1132) in ischemic stroke patients (p = 0.1 /11, 38, 61, 62/). Loss of consciousness was more common in SM (14.7%, 275/1876) than in ischemic stroke (10.2%, 390/3831) patients (p < 0.001 /11, 28, 34, 45, 46, 49, 52, 62, 64, 69/). Vomiting was also more common in SM patients 28.5% (162/569) vs. 18.8% (73/388) (p < 0.001 /11, 17, 36, 62/). Headache occured more frequently in SM patients 21.3% (269/1263) vs. 9.8% (202/2061) (p < 0.001) [
] and more of them were able to walk comparing to ischemic stroke patients: 51.38% (56/109) vs. 37.5% (84/224) (p = 0.016) although it was based on the results of one study [
Baseline characteristics of the 1149 patients recruited into the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2) randomized controlled trial.
]. No signs of stroke on physical examination could be found 33.7% (131/389) in SM and 10.5% (36/343) in ischemic stroke patients (p < 0.001) (Fig. 2).
CT was diagnostic in 80.2% (3481/4338) in ischemic stroke and 57.8% (884/1529) in SM patiens (p < 0.001 /11, 25, 26, 28, 32, 33, 36, 53, 64, 68/), while MRI was carried out in 41.5% (3098/7470) in ischemic stroke and 50% (787/1575) in SM patients (p < 0.001 /11,25,26,28, 32, 33, 36, 53, 59, 61, 64/). CT perfusion may help to differentiate between ischemic stroke and SM patients based on two studies [
]. CT perfusion was more likely to enable confirmation of clinical ischemic stroke diagnosis (odds ratio, 13.3) than was noncontrast CT and CT angiography (odds ratio, 6.4) or noncontrast CT alone (odds ratio, 3.3) [
Pearson C, Przyklenk K, Mika VH, Ayaz SI, Ellis M, Varade P, Tolomello R, Welch RD. Utility of point of care assessment of platelet reactivity (using the PFA-100®) to aid in diagnosis of stroke. Am J Emerg Med. 2017;35(5):802.e1‐802.e5.
Systolic blood pressure as a predictor of transient ischemic attack/minor stroke in emergency department patients under age 80: a prospective cohort study.
BE FAST Study Group. Diagnostic accuracy of plasma glial fibrillary acidic protein for differentiating intracerebral hemorrhage and cerebral ischemia in patients with symptoms of acute stroke.
Pearson C, Przyklenk K, Mika VH, Ayaz SI, Ellis M, Varade P, Tolomello R, Welch RD. Utility of point of care assessment of platelet reactivity (using the PFA-100®) to aid in diagnosis of stroke. Am J Emerg Med. 2017;35(5):802.e1‐802.e5.
Pearson C, Przyklenk K, Mika VH, Ayaz SI, Ellis M, Varade P, Tolomello R, Welch RD. Utility of point of care assessment of platelet reactivity (using the PFA-100®) to aid in diagnosis of stroke. Am J Emerg Med. 2017;35(5):802.e1‐802.e5.
2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2018;49:e46–e99.
Systolic blood pressure as a predictor of transient ischemic attack/minor stroke in emergency department patients under age 80: a prospective cohort study.
BE FAST Study Group. Diagnostic accuracy of plasma glial fibrillary acidic protein for differentiating intracerebral hemorrhage and cerebral ischemia in patients with symptoms of acute stroke.
Pearson C, Przyklenk K, Mika VH, Ayaz SI, Ellis M, Varade P, Tolomello R, Welch RD. Utility of point of care assessment of platelet reactivity (using the PFA-100®) to aid in diagnosis of stroke. Am J Emerg Med. 2017;35(5):802.e1‐802.e5.
Pearson C, Przyklenk K, Mika VH, Ayaz SI, Ellis M, Varade P, Tolomello R, Welch RD. Utility of point of care assessment of platelet reactivity (using the PFA-100®) to aid in diagnosis of stroke. Am J Emerg Med. 2017;35(5):802.e1‐802.e5.
Pearson C, Przyklenk K, Mika VH, Ayaz SI, Ellis M, Varade P, Tolomello R, Welch RD. Utility of point of care assessment of platelet reactivity (using the PFA-100®) to aid in diagnosis of stroke. Am J Emerg Med. 2017;35(5):802.e1‐802.e5.
Pearson C, Przyklenk K, Mika VH, Ayaz SI, Ellis M, Varade P, Tolomello R, Welch RD. Utility of point of care assessment of platelet reactivity (using the PFA-100®) to aid in diagnosis of stroke. Am J Emerg Med. 2017;35(5):802.e1‐802.e5.
Pearson C, Przyklenk K, Mika VH, Ayaz SI, Ellis M, Varade P, Tolomello R, Welch RD. Utility of point of care assessment of platelet reactivity (using the PFA-100®) to aid in diagnosis of stroke. Am J Emerg Med. 2017;35(5):802.e1‐802.e5.
]. 61.7% (10232/16586) of ischemic stroke patients were thrombolysed vs. 26.3% (635/2407) among SMs (p < 0.001). Three studies reported thrombectomy rates, 12.2% of ischemic stroke patients (140/1150) had revascularisation procedure, while no SM had thrombectomy (0/607) [